The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 02, 2019
Filed:
Dec. 31, 2018
Applicant:
Cyteir Therapeutics, Inc., Lexington, MA (US);
Inventors:
Alfredo C. Castro, Woburn, MA (US);
Casey Cameron McComas, Phoenixville, PA (US);
Joseph Vacca, Telford, PA (US);
Tyler Maclay, Cambridge, MA (US);
Assignee:
Cyteir Therapeutics, Inc., Lexington, MA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/14 (2006.01); C07D 417/04 (2006.01); C07D 277/30 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); C07D 417/12 (2006.01); A61P 37/00 (2006.01); C07D 277/42 (2006.01); C07D 277/28 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61P 25/28 (2018.01); A61P 35/00 (2018.01); A61P 37/00 (2018.01); A61P 37/02 (2018.01); C07D 277/28 (2013.01); C07D 277/30 (2013.01); C07D 277/42 (2013.01); C07D 417/04 (2013.01); C07D 417/12 (2013.01);
Abstract
This application is directed to inhibitors of RAD51 represented by the following structural formula, and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.